little red; little itching; they feel more energetic now than before getting the vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of ERYTHEMA (little red), PRURITUS (little itching) and ENERGY INCREASED (they feel more energetic now than before getting the vaccine) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cardiomyopathy since an unknown date, Hypertension since an unknown date, Diabetes mellitus since an unknown date, Pulmonary embolism since an unknown date and Liver resection (part of their liver removed) since an unknown date. Concomitant products included LISINOPRIL for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (little red), PRURITUS (little itching) and ENERGY INCREASED (they feel more energetic now than before getting the vaccine). At the time of the report, ERYTHEMA (little red), PRURITUS (little itching) and ENERGY INCREASED (they feel more energetic now than before getting the vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reported patient's medical history including "triple cervical disease".   Reported concomitant medications including Homeopathic medicines for drug use for unknown indication.  No treatment information was provided.   This case was linked to MOD-2021-023459 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of ERYTHEMA (little red), PRURITUS (little itching) and ENERGY INCREASED (they feel more energetic now than before getting the vaccine) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cardiomyopathy since an unknown date, Hypertension since an unknown date, Diabetes mellitus since an unknown date, Pulmonary embolism since an unknown date and Liver resection (part of their liver removed) since an unknown date. Concomitant products included LISINOPRIL for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (little red), PRURITUS (little itching) and ENERGY INCREASED (they feel more energetic now than before getting the vaccine). At the time of the report, ERYTHEMA (little red), PRURITUS (little itching) and ENERGY INCREASED (they feel more energetic now than before getting the vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reported patient's medical history including "triple cervical disease".   Reported concomitant medications including Homeopathic medicines for drug use for unknown indication.  No treatment information was provided.   This case was linked to MOD-2021-023459 (Patient Link).